CSDT is my Breakout Play of the Week
Hola Shmola Roaches!
Today I bring you CSDT as my latest hot stock alert!
CSDT operates as a development-stage, medical imaging device company. It develops optical diagnostic products that operate in conjunction with surgical and or evaluation procedures in real time.
CSDT recently won a 2 year grant worth $750,000 a year and this is just the tip of the iceberg.
With CSDT recently announcing that it expects to start testing its SkinSpect cancer screening devices in the University of Pittsburgh Medical Center’s melanoma clinic in early October now could be the prime time to strike before the frenzy begins. Check this out for more details
If that wasn’t enough to get your tentacles moving, did you know endoscopy represents a $2.3 billion market opportunity and melanoma detection a $6 billion market opportunity for CSDT!?
With CSDT well rooted in a very profitable market, I feel this could lead to significant revenue opportunities down the road.
So what do we see on the chart moving forward?
Well as I stated yesterday, CSDT is recently coming out of a very powerful “cup and handle” formation with the last few days representing the “handle” of the cup.
In this set up, we look for the handle to eventually break up higher than the right side of the cup which is at .075 price.
If this occurs then turn your attention to the 50 moving average line at .10 cents or an easy 25% higher than our current price.
Now here is where it gets really intriguing…
If CSDT can break over the 50 moving average line at .10 cents then the only other stopping point on the chart is the 200 moving average line at .17 cents. That would turn our possible total gain from 25% to well over 100%!
So get up off the lazy boy and scurry on over to your nearest dial up computer so you can pull CSDT up on your brokerage account. This sleeping giant could be on the verge of a major payday for us today and I wouldn’t want you to miss out on these el cheapo prices.
Good luck today Roaches, may the force be with you.
This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. BlueWave Advisors, LLC owns seventy five percent of the outstanding membership interests of StockHideout, LLC. Stock_Analyzer owns twenty five percent of the outstanding membership interests of StockHideout, LLC. BlueWave Advisors has been previously compensated Thirty Five Thousand dollars from Shazam Stocks, Inc (a non-controlling third party) for CSDT advertising and promotional services that have expired. Currently BlueWave Advisors has been compensated twelve thousand five hundred dollars from Echelon Global Partners, a non-controlling third party shareholder for CSDT advertising and promotion. StockHideout, LLC has been compensated a total of six thousand dollars from BlueWave Advisors (a non-affiliated third party) for CSDT advertising and promotional services. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. StockHideout, LLC, BlueWave Advisors, and their affiliates currently hold no shares in the profiled company.
While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
Leave a Response